2023 Q2 Form 10-Q Financial Statement

#000162828023017868 Filed on May 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $3.487M $4.747M $6.778M
YoY Change -36.43% -29.96% 311.79%
Cost Of Revenue $3.031M $4.386M $5.007M
YoY Change -23.56% -12.4% 623.55%
Gross Profit $456.0K $361.0K $1.771M
YoY Change -70.0% -79.62% 85.64%
Gross Profit Margin 13.08% 7.6% 26.13%
Selling, General & Admin $6.238M $5.840M $5.790M
YoY Change -13.11% 0.86% 74.71%
% of Gross Profit 1367.98% 1617.73% 326.93%
Research & Development $1.212M $1.772M $1.003M
YoY Change -35.39% 76.67% -4.66%
% of Gross Profit 265.79% 490.86% 56.63%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $8.653M $7.612M $6.793M
YoY Change -4.44% 12.06% 55.59%
Operating Profit -$8.197M -$7.251M -$5.022M
YoY Change 8.79% 44.38% 47.19%
Interest Expense $553.0K $537.0K $381.0K
YoY Change 102.56% 40.94% -82.83%
% of Operating Profit
Other Income/Expense, Net $1.673M $2.982M -$9.895M
YoY Change -117.54% -130.14% -9.18%
Pretax Income -$6.524M -$4.269M -$14.92M
YoY Change -61.78% -71.38% 4.26%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.524M -$4.269M -$14.92M
YoY Change -61.78% -71.38% 4.26%
Net Earnings / Revenue -187.09% -89.93% -220.08%
Basic Earnings Per Share -$0.06 -$0.04 -$0.15
Diluted Earnings Per Share -$0.06 -$0.04 -$0.15
COMMON SHARES
Basic Shares Outstanding 104.7M shares 104.0M shares 96.84M shares
Diluted Shares Outstanding 105.1M shares 103.2M shares 96.84M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.105M $694.0K $10.82M
YoY Change -59.15% -93.58% -53.92%
Cash & Equivalents $1.105M $694.0K $10.82M
Short-Term Investments
Other Short-Term Assets $695.0K $3.337M $25.54M
YoY Change -94.96% -86.93% 1251.22%
Inventory $2.168M $2.671M $4.699M
Prepaid Expenses
Receivables $863.0K $1.200M $1.219M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.831M $7.902M $42.27M
YoY Change -76.79% -81.31% 60.74%
LONG-TERM ASSETS
Property, Plant & Equipment $188.0K $206.0K $77.00K
YoY Change 29.66% 167.53% 541.67%
Goodwill $29.96M $31.14M $33.23M
YoY Change -9.61% -6.29% 28.24%
Intangibles $2.190M $2.357M $3.030M
YoY Change -23.37% -22.21% 3735.44%
Long-Term Investments
YoY Change
Other Assets $367.0K $367.0K $1.632M
YoY Change -78.15% -77.51% 81.33%
Total Long-Term Assets $35.96M $37.56M $39.15M
YoY Change -11.04% -4.08% 36.76%
TOTAL ASSETS
Total Short-Term Assets $4.831M $7.902M $42.27M
Total Long-Term Assets $35.96M $37.56M $39.15M
Total Assets $40.79M $45.46M $81.42M
YoY Change -33.39% -44.17% 48.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.350M $7.765M $6.809M
YoY Change 11.19% 14.04% -12.49%
Accrued Expenses $1.542M $2.506M $7.114M
YoY Change -77.82% -64.77% 123.01%
Deferred Revenue $1.092M $1.512M $3.263M
YoY Change -36.33% -53.66% 49.68%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $6.094M $5.687M $3.493M
YoY Change 200.05% 62.81% -65.11%
Total Short-Term Liabilities $19.25M $19.64M $26.12M
YoY Change -9.04% -24.84% -14.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $3.634M $3.920M $2.031M
YoY Change 17.11% 93.01% -41.97%
Total Long-Term Liabilities $3.634M $3.920M $2.031M
YoY Change 17.11% 93.01% -45.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.25M $19.64M $26.12M
Total Long-Term Liabilities $3.634M $3.920M $2.031M
Total Liabilities $22.88M $23.56M $29.43M
YoY Change -10.42% -19.97% -23.29%
SHAREHOLDERS EQUITY
Retained Earnings -$261.0M -$254.5M -$214.2M
YoY Change 12.84% 18.79% 33.81%
Common Stock $11.00K $10.00K $10.00K
YoY Change 10.0% 0.0% 42.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.91M $21.90M $51.99M
YoY Change
Total Liabilities & Shareholders Equity $40.79M $45.46M $81.42M
YoY Change -33.39% -44.17% 48.24%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$6.524M -$4.269M -$14.92M
YoY Change -61.78% -71.38% 4.26%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$5.178M -$7.382M -$10.17M
YoY Change 7.47% -27.42% 39.35%
INVESTING ACTIVITIES
Capital Expenditures $3.000K $6.000K -$80.00K
YoY Change -103.85% -107.5%
Acquisitions
YoY Change
Other Investing Activities $4.600M $10.79M -$489.0K
YoY Change -395.06% -2306.54% -55.55%
Cash From Investing Activities $4.597M $10.78M -$569.0K
YoY Change -380.82% -1995.25% -48.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 968.0K -$4.687M -$1.550M
YoY Change -161.81% 202.39% -105.55%
NET CHANGE
Cash From Operating Activities -5.178M -$7.382M -$10.17M
Cash From Investing Activities 4.597M $10.78M -$569.0K
Cash From Financing Activities 968.0K -$4.687M -$1.550M
Net Change In Cash 387.0K -$1.261M -$12.32M
YoY Change -104.82% -89.77% -163.1%
FREE CASH FLOW
Cash From Operating Activities -$5.178M -$7.382M -$10.17M
Capital Expenditures $3.000K $6.000K -$80.00K
Free Cash Flow -$5.181M -$7.388M -$10.09M
YoY Change 9.3% -26.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001665300
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
694000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1955000 usd
CY2023Q1 dei Entity File Number
EntityFileNumber
001-37862
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
PHUNWARE, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-1205798
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1002 West Avenue
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78701
CY2023Q1 dei City Area Code
CityAreaCode
512
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
693-4199
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
104658145 shares
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
198000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
198000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
1200000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
958000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
2671000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2780000 usd
CY2023Q1 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
2530000 usd
CY2022Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
10137000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
807000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1033000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
7902000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
16863000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
206000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
221000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
31136000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
31113000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2357000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2524000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3489000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3712000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
367000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
402000 usd
CY2023Q1 us-gaap Assets
Assets
45457000 usd
CY2022Q4 us-gaap Assets
Assets
54835000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7765000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7699000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2506000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2895000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
961000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
954000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1512000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2904000 usd
CY2023Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
1202000 usd
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
1202000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
5687000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9667000 usd
CY2023Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3000 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
256000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
19636000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25577000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1072000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1274000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2848000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3103000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
23556000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
29954000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
104469310 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
104007810 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
103153337 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
103153337 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
10000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
10000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
461500 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0 shares
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
475000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
277303000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
275562000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-449000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-472000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-254488000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-250219000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
21901000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
24881000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45457000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54835000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4747000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6778000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4386000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5007000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
361000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
1771000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1128000 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1485000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4712000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4305000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1772000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1003000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
7612000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
6793000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7251000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5022000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
537000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
381000 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
50000 usd
CY2022Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
9353000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
3214000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
26000 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-253000 usd
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
213000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
102000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2982000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9895000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4269000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14917000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4269000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14917000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
23000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-32000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4246000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14949000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103169000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103169000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96844000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96844000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
24881000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
58000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
347000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1336000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
23000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
475000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4269000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
21901000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
65277000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1125000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
521000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-32000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14917000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
51990000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4269000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14917000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
289000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
155000 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-253000 usd
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
213000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
3214000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
26000 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
50000 usd
CY2022Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
9353000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1362000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
564000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-357000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
71000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
245000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
248000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-241000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2063000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-261000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
687000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
67000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
219000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-89000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1489000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-345000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-173000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1594000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1001000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7382000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10171000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
10790000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
0 usd
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
489000 usd
CY2023Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
6000 usd
CY2022Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
80000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10784000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-569000 usd
CY2023Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
4270000 usd
CY2022Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
1566000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
58000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
475000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4687000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1550000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-32000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1261000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12322000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1955000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23137000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
694000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10815000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
434000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
204000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
0 usd
CY2022Q1 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
1125000 usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
347000 usd
CY2022Q1 us-gaap Stock Issued1
StockIssued1
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4269000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7382000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
Use of EstimatesThe preparation of financial statements in conformity with U.S. GAAP requires us to make certain estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates and such differences could be material.
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash, trade accounts receivable and our digital asset holdings.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we limit our exposure to credit loss by depositing our cash with established financial institutions that management believes have good credit ratings and represent minimal risk of loss of principal, our deposits, at times, may exceed federally insured limits. Collateral is not required for accounts receivable, and we believe the carrying value approximates fair value.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is currently no clearing house for our digital assets, including our bitcoin holdings, nor is there a central or major depository for the custody of our digital assets. There is a risk that some or all of our digital asset holdings could be lost or stolen. There can be no assurance that the custodians will maintain adequate insurance or that such coverage will cover losses with respect to our digital asset holdings. Further, transactions denominated in digital assets are irrevocable. Stolen or incorrectly transferred digital assets may be irretrievable. As a result, any incorrectly executed transactions could adversely our financial condition. The aggregate cost basis (prior to impairment) of our digital asset holdings was $8,817 and $37,737 at March 31, 2023 and December 31, 2022, respectively. </span></div>Collateral is not required for accounts receivable and we believe the carrying value approximates fair value.
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2681000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2968000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
82000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
0 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
38000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
50000 usd
CY2023Q1 us-gaap Other Inventory
OtherInventory
6000 usd
CY2022Q4 us-gaap Other Inventory
OtherInventory
30000 usd
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
136000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
268000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
2671000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2780000 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12979817 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10014132 shares
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4747000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6778000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1512000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2904000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1072000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1274000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2584000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4178000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2133000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5696000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.42
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q1 phun Number Of Security Token Sold
NumberOfSecurityTokenSold
115800000 phuntoken
CY2022Q1 phun Proceeds From Sale Of Security Token
ProceedsFromSaleOfSecurityToken
973000 usd
CY2022Q4 phun Security Token Issued
SecurityTokenIssued
377200000 phuntoken
CY2023Q1 phun Security Token Issued
SecurityTokenIssued
377200000 phuntoken
CY2023Q1 phun Security Token Authorized
SecurityTokenAuthorized
10000000000 phuntoken
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill Fair Value Disclosure
IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure
4708000 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
50000 usd
CY2022Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
9353000 usd
CY2023Q1 phun Indefinite Lived Intangible Assets Excluding Goodwill Gross
IndefiniteLivedIntangibleAssetsExcludingGoodwillGross
8817000 usd
CY2023Q1 phun Indefinite Lived Intangible Assets Accumulated Impairment
IndefiniteLivedIntangibleAssetsAccumulatedImpairment
6287000 usd
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2530000 usd
CY2022Q4 phun Indefinite Lived Intangible Assets Excluding Goodwill Gross
IndefiniteLivedIntangibleAssetsExcludingGoodwillGross
37737000 usd
CY2022Q4 phun Indefinite Lived Intangible Assets Accumulated Impairment
IndefiniteLivedIntangibleAssetsAccumulatedImpairment
27600000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
10137000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
10137000 usd
CY2023Q1 phun Indefinite Lived Intangible Assets Received From Customers Net Of Expenses
IndefiniteLivedIntangibleAssetsReceivedFromCustomersNetOfExpenses
19000 usd
CY2023Q1 phun Indefinite Lived Intangible Assets Exchanged
IndefiniteLivedIntangibleAssetsExchanged
0 usd
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Written Off Related To Sale Of Business Unit
IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit
10790000 usd
CY2023Q1 phun Indefinite Lived Intangible Assets Gain Loss From Sale
IndefiniteLivedIntangibleAssetsGainLossFromSale
3214000 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
50000 usd
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2530000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
537000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
381000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
325000 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
204000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
951000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1305000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
929000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
744000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
508000 usd
CY2023Q1 phun Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4437000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
628000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3809000 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
104007810 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
103153337 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
103153337 shares
CY2023Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
5000000 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
461500 shares
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
475000 usd
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6632561 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6632561 shares
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1362000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
564000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
16000 usd
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4747000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6778000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4269000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14917000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
31136000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
31113000 usd
CY2023Q1 us-gaap Assets
Assets
45457000 usd
CY2022Q4 us-gaap Assets
Assets
54835000 usd

Files In Submission

Name View Source Status
phun-20230331_cal.xml Edgar Link unprocessable
0001628280-23-017868-index-headers.html Edgar Link pending
0001628280-23-017868-index.html Edgar Link pending
0001628280-23-017868.txt Edgar Link pending
0001628280-23-017868-xbrl.zip Edgar Link pending
ex-311xcertificationxq12023.htm Edgar Link pending
ex-312xcertificationxq12023.htm Edgar Link pending
ex-321xcertificationxq12023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
phun-20230331.htm Edgar Link pending
phun-20230331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
phun-20230331_def.xml Edgar Link unprocessable
phun-20230331_lab.xml Edgar Link unprocessable
phun-20230331_pre.xml Edgar Link unprocessable
phun-20230331_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending